Skip to content

Preventing Nocebo Effects and Improving Compliance During the Removal of Transcutaneous K-Wires in the Outpatient Clinic Following Pediatric Osteosynthesis: A Pre-Post Intervention Study

Preventing Nocebo Effects and Improving Compliance During the Removal of Transcutaneous K-Wires in the Outpatient Clinic Following Pediatric Osteosynthesis: A Pre-Post Intervention Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00039867
Enrollment
200
Registered
2026-04-22
Start date
2026-04-02
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Fractures

Interventions

Group 1: Standard procedure for K-wire removal in the outpatient clinic. Monitoring via questionnaires (medical staff/parents). Group 2: After approximately 100 cases, staff will receive training in p

Sponsors

Klinik St. Hedwig, Barmherzige Brüder Regensburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: K-wire osteosynthesis is performed in the hospital with the K-wires left protruding and a cast applied, and wire removal is scheduled to take place in the outpatient clinic as part of the standard treatment.

Exclusion criteria

Exclusion criteria: Additional analgosedation, emergency situation, severe cognitive impairment, severe pre-existing psychiatric condition, lack of informed consent, insufficient language comprehension, prior participation in the study.

Design outcomes

Primary

MeasureTime frame
If approximately 100 cases were recorded before and after the intervention (i.e., staff training on positive communication). Well-being is measured for children (Smiley Scale) and parents (NRS), as well as peri-intervention anxiety using the mYPAS (assessed by staff and parents).

Countries

Germany

Contacts

Public ContactAlexander Hanke

Klinik St. Hedwig, Barmherzige Brüder Regensburg

alexander.hanke@barmherzige-regensburg.de+49 941 369 95324

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026